Sanara MedTech Inc. (SMTI)

Sanara MedTech Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sanara MedTech Inc. (SMTI) is a Medical - Instruments & Supplies company based in US with a market capitalization of $213.1M. Revenue grew 19.0% year-over-year and the company generated $2.2M in free cash flow. This page tracks SMTI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 141 employees · IPO Apr 7, 1994

Valuation

Valuation & price

$21.06as of May 17, 2026· -41.1% vs 52w high

P/E ratio

Latest-FY diluted EPS

35.93

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$35.28$25.81$16.34Jul 25Dec 25Jul 26
$16.3452-week range$35.75
Loading valuation history…

Fundamentals

Key fundamentals

$213.1M

Market cap

19.0%

Revenue growth (YoY)

90.1%

Gross margin

$2.2M

Free cash flow (USD)

$31.6M

Net debt

1.6%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$5.5M$103.1M

Free cash flow by year

20162025

$406.2K$2.2M

Gross margin by year

20212025

90.4%90.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventJun 9, 2026Filing

    Annual Meeting Results

  • 8-K eventJun 4, 2026Filing

    Termination of Agreement

  • Quarterly reportMay 12, 2026Filing

    10-Q Filed

  • 8-K eventMay 11, 2026Filing

    Earnings Release

Questions

Frequently asked questions

What is Sanara MedTech Inc.'s market cap?

Sanara MedTech Inc. (SMTI) has a market capitalization of $213.1M.

What is SMTI's P/E ratio?

A meaningful P/E ratio is not available for SMTI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SMTI's price-to-book (P/B) ratio?

SMTI trades at 35.93 times book value per share.

Are insiders buying SMTI stock?

SEC Form 4 filings show no open-market insider buys at Sanara MedTech Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.